HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.

AbstractBACKGROUND:
Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused by CoNS is incomplete.
METHOD:
The International Collaboration on Endocarditis-Prospective Cohort Study includes patients with endocarditis from 61 centers in 28 countries. Patients with definite cases of NVE caused by CoNS who were enrolled during the period June 2000-August 2006 were compared with patients with definite cases of NVE caused by Staphylococcus aureus and patients with NVE caused by viridans group streptococci. Multivariable logistic regression was used to determine factors associated with death in patients with NVE caused by CoNS.
RESULTS:
Of 1635 patients with definite NVE and no history of injection drug use, 128 (7.8%) had NVE due to CoNS. Health care-associated infection occurred in 63 patients (49%) with NVE caused by CoNS. Comorbidities, long-term intravascular catheter use, and history of recent invasive procedures were similar among patients with NVE caused by CoNS and among patients with NVE caused by S. aureus. Surgical treatment for endocarditis occurred more frequently in patients with NVE due to CoNS (76 patients [60%]) than in patients with NVE due to S. aureus (150 [33%]; P=.01) or in patients with NVE due to viridans group streptococci (149 [44%]; P=.01). Despite the high rate of surgical procedures among patients with NVE due to CoNS, the mortality rates among patients with NVE due to CoNS and among patients with NVE due to S. aureus were similar (32 patients [25%] and 124 patients [27%], respectively; P=.44); the mortality rate among patients with NVE due to CoNS was higher than that among patients with NVE due to viridans group streptococci (24 [7.0%]; P=.01). Persistent bacteremia (odds ratio, 2.65; 95% confidence interval, 1.08-6.51), congestive heart failure (odds ratio, 3.35; 95% confidence interval, 1.57-7.12), and chronic illness (odds ratio, 2.86; 95% confidence interval, 1.34-6.06) were independently associated with death in patients with NVE due to CoNS (c index, 0.73).
CONCLUSIONS:
CoNS have emerged as an important cause of NVE in both community and health care settings. Despite high rates of surgical therapy, NVE caused by CoNS is associated with poor outcomes.
AuthorsVivian H Chu, Christopher W Woods, Jose M Miro, Bruno Hoen, Christopher H Cabell, Paul A Pappas, Jerome Federspiel, Eugene Athan, Martin E Stryjewski, Francisco Nacinovich, Francesc Marco, Donald P Levine, Tom S Elliott, Claudio Q Fortes, Pilar Tornos, David L Gordon, Riccardo Utili, Francois Delahaye, G Ralph Corey, Vance G Fowler Jr, International Collaboration on Endocarditis-Prospective Cohort Study Group
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 46 Issue 2 Pg. 232-42 (Jan 15 2008) ISSN: 1537-6591 [Electronic] United States
PMID18171255 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Coagulase
Topics
  • Adult
  • Aged
  • Coagulase (deficiency)
  • Community-Acquired Infections (microbiology)
  • Cross Infection (microbiology)
  • Endocarditis, Bacterial (microbiology, surgery)
  • Female
  • Heart Failure (microbiology)
  • Heart Valve Diseases (microbiology, surgery)
  • Humans
  • Male
  • Methicillin Resistance
  • Middle Aged
  • Pacemaker, Artificial
  • Prospective Studies
  • Staphylococcus (drug effects, enzymology, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: